Premium
Three current and former executives of Rx Propellant, a life sciences-focused infrastructure provider owned by private equity firm Actis, have come together to float a venture capital fund to bet on biotech startups. Vishal Goel and Jasmeet Chhabra, who have been engaged in real estate investments for nearly two decades, have ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.